Target intelligence / Profile preview

Phosphatidate cytidylyltransferase, mitochondrial (TAMM41)

Target
TAMM41
Molecular classification
Enzyme, Mitochondrial protein, Phosphatidate cytidylyltransferase
01

Overview

Phosphatidate cytidylyltransferase, mitochondrial (TAMM41) is an enzyme localized in the mitochondrial matrix, required for the biosynthesis of cardiolipin, an essential mitochondrial phospholipid involved in membrane integrity and function[4][8]. TAMM41 catalyzes the CDP-diacylglycerol synthesis step in the cardiolipin pathway, and is conserved from yeast (TAM41) to humans[4]. Mutations or loss of TAMM41 function are associated with combined oxidative phosphorylation deficiency 56 (COXPD56), a mitochondrial disorder marked by defects in cardiolipin synthesis resulting in impaired mitochondrial respiratory chain function[7]. This protein is not currently a direct therapeutic target or receptor, but its role in mitochondrial pathophysiology is clinically relevant.

Other names
TAM41 mitochondrial translocator assembly and maintenance homologC3orf31DKFZp434E0519MGC16471RAM41CDP-diacylglycerol synthaseCDP-DAG synthaseMitochondrial translocator assembly and maintenance protein 41 homologMMP37-like proteinCOXPD56
02

Biological functions

Cardiolipin biosynthesisMitochondrial membrane biogenesisMaintenance of mitochondrial integrityPhospholipid metabolism
03

Disease associations

Mitochondrial disease (e.g., COXPD56, combined oxidative phosphorylation deficiency 56)Other mitochondrial dysfunction
04

Safety considerations

Loss of function may impair mitochondrial membrane integrity and phospholipid biosynthesis, which can result in mitochondrial disease

Beyond the preview

Go deeper on Phosphatidate cytidylyltransferase, mitochondrial (TAMM41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidate cytidylyltransferase, mitochondrial (TAMM41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call